Price target
352.070.000.00%
The 21 analysts offering 1 year price forecasts for GNMSF have a max estimate of — and a min estimate of —.
Analyst rating
Based on 28 analysts giving stock ratings to GNMSF in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GNMSF EPS for the last quarter is 2.96 USD despite the estimation of 3.13 USD. In the next quarter EPS is expected to reach 3.49 USD. Track more of Genmab A/S financials and stay on top of what is up with the company.
In the next quarter Genmab A/S revenue is expected to reach 882.29 M USD. Check out Genmab A/S revenue and earnings and make informed decisions.
According to analysts, GNMSF price target is 352.07 USD with a max estimate of 493.69 USD and a min estimate of 231.65 USD. Check if this forecast comes true in a year, meanwhile watch Genmab A/S stock price chart and keep track of the current situation with GNMSF news and stock market news.
We've gathered opinions of 28 analysts rating GNMSF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.